These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23732959)

  • 21. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease.
    Ryu ES; Kim MJ; Shin HS; Jang YH; Choi HS; Jo I; Johnson RJ; Kang DH
    Am J Physiol Renal Physiol; 2013 Mar; 304(5):F471-80. PubMed ID: 23283992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.
    Ali BH; Adham SA; Al Za'abi M; Waly MI; Yasin J; Nemmar A; Schupp N
    PLoS One; 2015; 10(4):e0125285. PubMed ID: 25909514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erhuang Formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses.
    Zhang CY; Zhu JY; Ye Y; Zhang M; Zhang LJ; Wang SJ; Song YN; Zhang H
    Biomed Pharmacother; 2017 Nov; 95():520-528. PubMed ID: 28866419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion.
    Wang S; Fang Y; Yu X; Guo L; Zhang X; Xia D
    Biomed Pharmacother; 2019 Mar; 111():162-168. PubMed ID: 30579255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure.
    Nemmar A; Karaca T; Beegam S; Yuvaraju P; Yasin J; Hamadi NK; Ali BH
    Cell Physiol Biochem; 2016; 38(5):1703-13. PubMed ID: 27160713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of sildenafil on rats with adenine-Induced chronic kidney disease.
    Ali BH; Al Za'abi M; Adham SA; Al Suleimani Y; Karaca T; Manoj P; Al Kalbani J; Yasin J; Nemmar A
    Biomed Pharmacother; 2018 Dec; 108():391-402. PubMed ID: 30236848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
    Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of Serum Uric Acid Associated with Attenuation of Renal Injury, Inflammation and Macrophages M1/M2 Ratio in Hyperuricemic Mice Model.
    Haryono A; Nugrahaningsih DAA; Sari DCR; Romi MM; Arfian N
    Kobe J Med Sci; 2018 Oct; 64(3):E107-E114. PubMed ID: 30666040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exploration on the establishment of animal models for gouty nephropathy complicated with chronic renal failure].
    Xing RL; Meng DM; Ren W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1409-13. PubMed ID: 22097216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotoxicity induced by a single dose of adenine: effects of 4-aminopyrazolo[3,4-d]pyrimidine and allopurinol.
    Minami T; Nakagawa H; Ichii M; Kadota E; Okazaki Y
    Biol Pharm Bull; 1994 Feb; 17(2):201-6. PubMed ID: 8205116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuing exposure to low-dose nonylphenol aggravates adenine-induced chronic renal dysfunction and role of rosuvastatin therapy.
    Yen CH; Sun CK; Leu S; Wallace CG; Lin YC; Chang LT; Chen YL; Tsa TH; Kao YH; Shao PL; Hsieh CY; Chen YT; Yip HK
    J Transl Med; 2012 Jul; 10():147. PubMed ID: 22812704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalpol Attenuates Oxidative Stress and Inflammation via Mechanisms Involving Sirtuin-1 Activation and NF-κB Inhibition in Experimentally-Induced Chronic Kidney Disease.
    Zaaba NE; Al-Salam S; Beegam S; Elzaki O; Yasin J; Nemmar A
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.
    Yen CH; Lin KC; Leu S; Sun CK; Chang LT; Chai HT; Chung SY; Chang HW; Ko SF; Chen YT; Yip HK
    Eur J Pharm Sci; 2012 Aug; 46(5):455-67. PubMed ID: 22484332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
    Shen B; Hagiwara M; Yao YY; Chao L; Chao J
    Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roflumilast alleviates adenine-induced chronic kidney disease by regulating inflammatory biomarkers.
    Patel P; Patel S; Chudasama P; Soni S; Raval M
    Eur J Pharmacol; 2023 Jun; 949():175731. PubMed ID: 37075855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
    Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
    J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.